oral hGnRH-R hormone receptor antagonist
to treat of uterine fibroids, Ph. I completed
from cell-based 2.5M cmpd HTS + opt.
J. Med. Chem., Oct. 22, 2020 issue
Bayer AG, Berlin, DE
BAY 1214784
October’s molecule, the Bayer hGnRH-R antagonist BAY 1214784, is intended as an oral, once-daily treatment for uterine fibroids, a highly common problem in adult women that can lead to infertility. Existing…